There is evidence that KP participates in the inflammatory mechanisms of the neurogenic manifestations of autoimmune diseases through the action of indoleamine 2,3-dioxygenase (IDO), the rate-limiting enzyme in tryptophan degradation [11,12,13,14,15]. This evidence concerns the gene NPPA and autoimmune disease.